Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Ferring Pharmaceuticals A/S
Sponsor

Ferring Pharmaceuticals A/S

Denmark Amager Strandvej 405, 2770, Denmark

About the sponsor

Clinical research in women undergoing controlled ovarian stimulation, in vitro fertilisation, and intracytoplasmic sperm injection focuses on improving ovarian response and treatment support within fertility care.

  • Controlled ovarian stimulation
  • IVF and ICSI cycles
  • Gonadotropin-based fertility treatment

The fertility portfolio also includes investigation of treatment combinations used in assisted reproductive technologies and related endocrine support.

About Specializations

Ferring Pharmaceuticals A/S runs clinical trials in conditions such as Bladder transitional cell carcinoma, Transitional cell carcinoma, Infertility male, Infertility female, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Bladder transitional cell carcinoma

Recruiting

Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Ferring Pharmaceuticals A/S

Bladder transitional cell carcinoma

Recruiting

Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Nadofaragene firadenovec
  • Sponsor:Ferring Pharmaceuticals A/S

Transitional cell carcinoma

Not yet recruiting

Safety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nadofaragene firadenovec
  • Sponsor:Ferring Pharmaceuticals A/S

Infertility male

Not recruiting

Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Follitropin Delta
  • Sponsor:Ferring Pharmaceuticals A/S

Infertility female+1

Not recruiting

Study on Ovarian Response in Women with Infertility Using Follitropin Delta and Menotrophin During Assisted Reproductive Technology

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Follitropin Delta
  • Sponsor:Ferring Pharmaceuticals A/S

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.